Evaluable [ftcn]    
Efficacy [qlco]    
Safeties [hcpp]    
Evolution [genf]    
Renal function [ortf]    
Early [tmco]    
Initial [menp]    
reduction [npop]    
de novo [idcn]    
Liver [bpoc]    
Transplant Recipients [podg]    
Study Protocol [inpr]    
Background [cnce]    
Introduction [hlca]    
Calcineurin inhibitor [moft]    
LED [mnob]    
Improved [qlco]    
Survival Rate [qnco]    
Liver [bpoc]    
Transplant Recipients [podg]    
Long-term [tmco]    
use [ftcn]    
Calcineurin inhibitor [moft]    
Associated [qlco]    
High Risk [qlco]    
Renal Failure, Chronic [dsyn]    
Neurotoxicity [inpo]    
de novo [idcn]    
malignancies [neop]    
Recurrence [phpr]    
Hepatitis C Infection [dsyn]    
Viral [ftcn]    
Hepatocellular carcinoma [neop]    
Several [qnco]    
studies [lbpr]    
Show [inpr]    
Potential [qlco]    
Provide [acty]    
Protection [fndg]    
viral replication [orgf]    
malignancies [neop]    
progress [patf]    
Fibrosis [patf]    
PREVENT [phsu]    
nephrotoxicity [inpo]    
Calcineurin inhibitor [phsu]    
reduction [npop]    
compromise [fndg]    
Efficacy [qlco]    
studies [mnob]    
Evaluable [ftcn]    
Effect [qlco]    
Early [tmco]    
Initial [menp]    
de novo [idcn]    
Liver [bpoc]    
Transplant Recipients [podg]    
Method [inpr]    
Design [acty]    
ONGOING [idcn]    
month [tmco]    
Multi [qnco]    
Center [spco]    
OPEN LABEL [resa]    
Controlled Study [resa]    
Aim [idcn]    
de novo [idcn]    
Liver [bpoc]    
Transplant Recipients [podg]    
Center [spco]    
Germany [geoa]    
patient [podg]    
RANDOM [resa]    
1+ [qnco]    
Ratio [qnco]    
7 days [tmco]    
Post [tmco]    
Transplant [topp]    
To [qlco]    
Receive [qlco]    
Trough [qnco]    
Level 3 [inpr]    
ng/mL [qnco]    
Reduced [qlco]    
Trough [qnco]    
Level [qlco]    
>5 [qnco]    
ng/mL [qnco]    
Standard [qlco]    
Trough [qnco]    
Level [qlco]    
ng/mL [qnco]    
ENTER [ftcn]    
Run-in Period [tmco]    
3 Days [tmco]    
Post [tmco]    
Transplant [topp]    
Run-in Period [tmco]    
patient [podg]    
TREAT [topp]    
Induction Therapy [topp]    
Local [spco]    
practice [menp]    
RANDOM [resa]    
Stratified [qlco]    
Hepatitis C status [fndg]    
Viral [ftcn]    
Model [inpr]    
End Stage Liver Disease [dsyn]    
Score [qnco]    
Transplant [topp]    
Primary [qlco]    
Object [inpr]    
studies [mnob]    
To [qlco]    
Exhibit [inpr]    
Superior [spco]    
Renal function [ortf]    
Estimate [qnco]    
Glomerular Filtration Rate [diap]    
Assess [acty]    
BY [geoa]    
Modification [ftcn]    
diet renal disease [topp]    
Formula [inpr]    
Reduced [qlco]    
Compare [acty]    
Standard [qlco]    
month [tmco]    
Object [inpr]    
To [qlco]    
Assess [acty]    
Incidence [qnco]    
TREAT [topp]    
biopsied [diap]    
Proven [qlco]    
Acute Rejection [fndg]    
graft loss [patf]    
Death [orgf]    
Incidence [qnco]    
Component [mnob]    
Composite [qlco]    
Efficacy [qlco]    
End Point [qlco]    
Renal function [ortf]    
Estimate [qnco]    
Glomerular Filtration Rate [diap]    
Using [ftcn]    
Various [irda]    
Formula [inpr]    
Modification [ftcn]    
diet renal disease [topp]    
Chronic kidney disease [dsyn]    
Epidemiologic [bmod]    
Collaboration [socb]    
Formula [inpr]    
Incidence [qnco]    
Proteinuria [fndg]    
Incidence [qnco]    
Adverse event [fndg]    
Serious Adverse Event [fndg]    
Incidence [qnco]    
Severe [qlco]    
Cytomegalovirus [virs]    
Hepatitis C Infection [dsyn]    
Viral [ftcn]    
Hepatitis C [dsyn]    
Viral [ftcn]    
Relate [orch]    
Fibrosis [patf]    
Discussion [topp]    
This [euka]    
studies [mnob]    
Aim [idcn]    
To [qlco]    
Superior [spco]    
Renal function [ortf]    
Efficacy [qlco]    
Safeties [hcpp]    
de novo [idcn]    
Liver [bpoc]    
Transplant Recipients [podg]    
Receive [qlco]    
Reduced [qlco]    
Compare [acty]    
Standard [qlco]    
This [euka]    
studies [mnob]    
Evaluable [ftcn]    
Antiviral [phsu]    
Benefit [qnco]    
Early [tmco]    
Initial [menp]    
